Radiopharm Theranostics RADX
NASDAQ RADX
$0.88 -0.07 (-7.70%)
At close: Nov 9, 2026 · 4:00 PM EST

Radiopharm Theranostics (RADX) Share-based Compensation (2023)

Updated

Radiopharm Theranostics (RADX) reported Share-based Compensation of -$16,340 for FY2026 (year ended Jun 30, 2026), compared with -$1.9 million in FY2025.

Analysis

Radiopharm Theranostics (RADX) Share-based Compensation (2023) Analysis & Trends

Dating back to FY2023, Radiopharm Theranostics' Share-based Compensation record includes 4 fiscal years.

  • According to Business Quant data, Share-based Compensation came in at -$1.9 million in FY2025, -$2.64 million in FY2024 and -$3.04 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 200.00 Mn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 357.00 Mn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 160.00 Mn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 369.00 Mn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 128.00 Mn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 234.00 Mn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 362.00 Mn
10 Radiopharm Theranostics 2.70 Bn 2.62 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -3.04 Mn
API Access

Radiopharm Theranostics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RADX&period=max&api_key=YOUR_API_KEY